期刊文献+

36例解甘露醇罗尔斯顿菌所致老年患者医院获得性肺炎的临床分析 被引量:8

Clinical analysis of 36 elderly Patients with Hospital-acquired Pneumonia caused by Ralstonia mannitolilytica
下载PDF
导出
摘要 目的探讨解甘露醇罗尔斯顿菌所致老年患者医院获得性肺炎的临床特点及治疗方法。方法回顾性分析36例解甘露醇罗尔斯顿菌所致老年患者医院获得性肺炎病例。结果解甘露醇罗尔斯顿菌所致肺炎多发生于接受机械通气治疗的患者,25.0%无发热,白细胞计数升高者仅占50.0%,而中性粒细胞百分比升高者为97.2%;胸部影像学主要表现为支气管肺炎;分离菌对氨曲南耐药率为100.0%,对美罗培南、头孢哌酮耐药率分别为97.5%、95.0%;对分离菌较为敏感的抗菌药物分别为复方新诺明(100.0%)、头孢吡肟(100.0%)、左氧氟沙星(97.5%)、头孢哌酮/舒巴坦(95.0%)。初始治疗应用的抗菌药物主要为三代头孢菌素类/酶抑制药(55.6%)、碳青霉烯类(50.0%)、喹诺酮类(30.6%)、哌拉西林/酶抑制药(30.6%)。治疗终点,治愈好转26例(72.2%),30d病死率为25.0%。结论对于解甘露醇罗尔斯顿菌所致老年患者医院获得性肺炎,应用β-内酰胺类/β-内酰胺酶抑制药有一定疗效。 Objective To study the clinical features and therapies of hospital-acquired pneumonia (HAP) caused by R. mannitolilytica. Methods The clinical data on 36 elderly patients with HAP caused by R. mannitolilytica were analyzed retrospectively. Results Pneumonia caused by R. mannitolilytica often occurred in patients who underwent mechanical ventilation treatment. Nonfever patients accounted for 25.0% ,while patients with increased number of WBC accounted for 50.0%, in which the increase of neutrophils was predominant(97.2%). Chest imaging indentified Bronchopneumonia as the prevalent condition. Resistant rates to aztreon- am, meropenem and cefoperazone were 100.0%, 97.5% and 95.0% respectively. The antibiotics, to which R. mannitolilytica was more sensitive,were the following:trimethoprim-sulfamethoxazole(100.0%),cefepime (100.0%),1evofloxacin(97.5%),and cefoperazone/sul- bactam(95.0%). The initial use of antibiotics included the 3rd generation cephalosporins/β-laetamase inhibitors(55.6%), carbopenems (50.0%), quinolones (30.6%), and piperacillin/β-1aetamase inhibitors (30.6%). The condition of 26 patients (72.2%) improved, while 9 patients (25.0%) died in 30 days. Conclusions β-1actams/β-1actamase inhibitors are effective in the treatment of elderly patients with HAP caused by R.mannitolilytica.
出处 《中华保健医学杂志》 2013年第1期6-8,共3页 Chinese Journal of Health Care and Medicine
基金 解放军总医院临床科研扶持基金(2012FC-TSYS-3053)
关键词 解甘露醇罗尔斯顿菌 医院获得性肺炎 老年患者 Ralstonia mannitolilytica Hospital-acquired pneumonia Elderly
  • 相关文献

参考文献7

  • 1Coenye T,Goris J,Spilker T,et al. Characterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis pa- tients and description of Inquilinus limosus gen. nov. sp. Nov[J]. J Clin Microbiol, 2002,40 : 2062-2069.
  • 2夏东,曹恂.168例老年肺部感染患者临床特点分析[J].中华医院感染学杂志,2011,21(6):1114-1115. 被引量:30
  • 3医院获得性肺炎诊断和治疗指南(草案)[J].中华结核和呼吸杂志,1999,22(4):201-208. 被引量:2164
  • 4李金钟,李中华,刘利平.罗尔斯顿菌属和亲铜菌属的研究进展[J].国际检验医学杂志,2008,29(5):437-439. 被引量:16
  • 5Popov DA,Vostrikova T. The first experience of application of PCR techniques in real-time mode to diagnose bacteriemia dur- ing postoperational period in cardiosurgery patients[J]. Klin Lab Diagn, 2011,8:49-52.
  • 6Degand N,Carbonnelle E, Dauphin B,et al. Matrix-assisted laser desorption ionization-time of flight mass spectrometry for identifi cation of nonfermenting gram-negative bacilli isolated from cystic fibrosis patients[J]. J Clin Microbio1,2008,46: 3361-3367.
  • 7Daxboeck F,Stadler M,Assadima O,et al. Characterization of clinically isolated Ralstonia mannitolilytica strains using random am plification of polymorphic DNA(RAPD)typing and antimicro- bial sensitivity,and comparison of the classification efficacy of phenotypic and genotypic assays [J]. J Med Microbiol, 2005,54: 55-61.

二级参考文献16

  • 1Vaneechoutte M, Kampfer P, De-Baere T, et al. Wautersia gennov. , a novel genus accommodating the phylogenetic lineage including Ralstonia eutropha and related species, and proposal of Ralstonia [Pseudomonas] syzygii (Roberts et al. 1990) comb. nov[J].Int J Syst Evol Microbiol, 2004, 54(Pt 2) : 317-327.
  • 2Vandamme P, Coenye T. Taxonomy of the genus Cupriavidus: a tale of lost and found [J].Int J Syst Evol Microbiol, 2004, 54(Pt 6):2 285-2 289.
  • 3Coenye T, Goris J, De-Vos P, et al. Classification of Ralstonia pickettii-like isolates from the environment and clinical samples as Ralstonia insidiosa sp. nov [J].Int J Syst Evol Microbiol, 2003, 53(Pt 4) : 1075-1080.
  • 4Coenye T, Vandamme P, LiPuma JJ. Ralstonia respiraculi sp. nov. , isolated from the respiratory tract of cystic fibrosis patients [J]. Int J Syst Evol Microbiol, 2003, 53(Pt 5): 1 339-1 342.
  • 5Coenye T, Vandamme P, LiPuma JJ. Infection by Ralstonia species in cystic fibrosis patients : identification of R. pickettii and R. mannitolilytica by polymerase chain reaction [J]. Emerg Infect Dis, 2002, 8(7): 692-696.
  • 6Coenye T, Spilker T, Reik R, et al. Use of PCR analyses to define the distribution of Ralstonia species recovered from patients with cystic fibrosis [J]. J Clin Microbiol, 2005, 43(7): 3 463-3 466.
  • 7Daxboeck F, Stadler M, Assadian O, et al. Characterization of clinically isolated Ralstonia mannitolilytica strains using random amplification of polymorphic DNA (RAPD) typing and antimicrobial sensitivity, and comparison of the classification efficacy of phenotypic and genotypic assays[J]. J Med Microbiol, 2005, 54 (Pt 1): 55-61.
  • 8Zellweger C, Bodmer T, Tauber MG, et al. Failure of ceftriaxone in an intravenous drug user with invasive infection due to Ralstonia pickettii[J]. Infection, 2004, 32(4): 246-248.
  • 9Kimura AC, Calvet H, Higa JI, et al. Outbreak of Ralstonia pickettii bacteremia in a neonatal intensive care unit[J].Pediatr Infect Dis J, 2005, 24(12): 1 099-1 103.
  • 10Ryan MP, Pembroke JT, Adley CC. Ralstonia pickettii: a persistent gram-negative nosocomial infectious organism[J]. J Hosp Infect, 2006, 62(3):278-284.

共引文献2204

同被引文献61

  • 1刘淑芳,张青山,王风秀.耐甲氧西林金黄色葡萄球菌感染治疗药物的选择[J].医药导报,2006,25(1):78-80. 被引量:15
  • 2顾正平,朱亚虹,陆惠平.头孢哌酮致不良反应454例文献分析[J].医药导报,2007,26(2):204-205. 被引量:21
  • 3Ito W,Takeda M,Kayaba H,et al. Clinical evaluation after anotification policy of linezolid use: a ease series of patients[J]. J Chemother, 2009,21 ( 1 ) : 52-57.
  • 4Meryl H,Somero Michael S,et al. Early microbiological response to linezolid vs vancomycin in ventilator-associated pneumonia due to methicillin-resistant staphylococcus aureus [J]. Chest, 2008,134(6) :200-207.
  • 5Kohno S,Yamaguchi K,Aikawa N,et al. Linezolid versus vancomycin for the treatment of infections caused by methicillin- resistant staphylococcus aureus in Japan [J]. J Antimicrob Chemother, 2007,6(6) : 1361-1369.
  • 6Lin DF,Zhang YY,Wu JF,et al. Linezolid for the treatment of infections caused by Gram-positive pathogens in China[J]. Int J Antimicrob Agents, 2008,32 (3) : 24-1-249.
  • 7Fomin P,Beuran M,Gradauskas A. Tigecycline is efficacious in the treatment of complicated intra-abdoininal infections[J]. Int J Surg, 2005,3 ( 1 ) : 35-47.
  • 8Fomin P,Koalov S,Cooper A,et al. The efficacy and safety of tigecycline for the treatment of complicated intra - abdominalinfections - the European experience[J].J Chemother, 2008, (20sl) : 12-19.
  • 9Eckmann C,Montravers P,Bassetti M,et ak Efficacy of tigecycline for the treatment of complicated intra-abdominal infections in real-lifeelinical practice from five European observational studies[J]. J Antimicrob Chemother,2013,68(s2): 25-35.
  • 10Bassetti M,Eckmann C,Bodmann KF,et al. Prescription behaviours for tigecycline in real-life clinical practice from five European observational studies [ J ]. J Antimicrob Chemother, 2013,68 (s2) : 5-14.

引证文献8

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部